Read about the latest news and developments at IDT Biologika, including the company’s growth, innovations and community involvement.
You can also access our entire archive of press releases and follow our activity on social media.
IDT Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseases more info
CEPI Awards Contract Worth Up To USD$36 million to Consortium led by IDT to Develop MERS Vaccine more info
Prime Minister hails exemplary success story more info
The pharmaceuticals company intends to use this takeover to continue expanding its herd-specific vaccine business more info
RT @PBOAssoc: Member news: @idtbiologika Biologika Awarded 10-Year NIH Contract to Manufacture Vaccines and Biologics for Infectious Diseas… more info
RT @IMG_ST: German region for #pharmaceuticals #SaxonyAnhalt: 20 companies at the @CPhIWW 2018 in Madrid. Like #cytostatics producer Oncot… more info
RT @vaccinenation: We are so pleased to have the sponsorship of @idtbiologika for the WVC EU this year. Thank you very much, we can't wait… more info